ADMA BIOLOGICS, INC. (ADMA) Operating cash flow 2016–2025
ADMA BIOLOGICS, INC. (ADMA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$50.4MFY2025 · since FY2016: -$18.3M → $50.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $50.4M | -57.5% |
| FY2024 | $118.7M | +1248.5% |
| FY2023 | $8.8M | +114.8% |
| FY2022 | -$59.5M | +47.0% |
| FY2021 | -$112.4M | -10.2% |
| FY2020 | -$102.0M | -33.9% |
| FY2019 | -$76.2M | -21.6% |
| FY2018 | -$62.7M | -68.2% |
| FY2017 | -$37.3M | -104.0% |
| FY2016 | -$18.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ADMA financial trends
ADMA RevenueADMA Net incomeADMA Net marginADMA Gross profitADMA Gross marginADMA Operating incomeADMA Operating marginADMA Free cash flowADMA Capital expendituresADMA Return on equityADMA Stock buybacksADMA Dividends paidADMA Total assetsADMA Total liabilitiesADMA Shareholders’ equityADMA overview →